• 1
    Cummings J. Canine Inflammatory Neuropathies. Philadelphia, PA: WB Saunders; 1992:10341037.
  • 2
    Kingma FJ CE. A paralytic syndrome in coonhounds. N Am Vet J 1954;35:115117.
  • 3
    Northington JW, Brown MJ. Acute canine idiopathic polyneuropathy. A Guillain-Barre-like syndrome in dogs. J Neurol Sci 1982;56:259273.
  • 4
    Cummings JF, de Lahunta A, Holmes DF, et al. Coonhound paralysis. Further clinical studies and electron microscopic observations. Acta Neuropathol 1982;56:167178.
  • 5
    Cummings JF, Haas DC. Coonhound paralysis. An acute idiopathic polyradiculoneuritis in dogs resembling the Landry-Guillain-Barre syndrome. J Neurol Sci 1966;4:5181.
  • 6
    Cuddon PA. Electrophysiologic assessment of acute polyradiculoneuropathy in dogs: Comparison with Guillain-Barre syndrome in people. J Vet Intern Med 1998;12:294303.
  • 7
    Holmes DF, Schultz RD, Cummings JF, et al. Experimental coonhound paralysis: Animal model of Guillain-Barre syndrome. Neurology 1979;29:11861187.
  • 8
    Hughes RA, Hadden RD, Gregson NA, et al. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 1999;100:7497.
  • 9
    Cook SD, Dowling PC, Murray MR, et al. Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 1971;24:136144.
  • 10
    Cook SD, Dowling PC. The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barre syndrome. Ann Neurol 1981;9 (Suppl):7079.
  • 11
    Sawant-Mane S, Clark MB, Koski CL. In vitro demyelination by serum antibody from patients with Guillain-Barre syndrome requires terminal complement complexes. Ann Neurol 1991;29:397404.
  • 12
    Koski CL, Humphrey R, Shin ML. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: Quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc Natl Acad Sci USA 1985;82:905909.
  • 13
    Linington C, Brostoff S. Peripheral Nerve Antigens, 3rd ed. Philadelphia, PA: WB Saunders; 1993:404417.
  • 14
    Hartung H, Stoll G, Toyka K. Immune Reactions in the Peripheral Nervous System, 3rd ed. Philadelphia, PA: WB Saunders; 1993:418443.
  • 15
    Arnason B. Inflammatory Polyradiculoneuropathies, 1st ed. Philadelphia, PA: WB Saunders; 1975:11101148.
  • 16
    Melnick S, Flewett T. Role of infection in the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1964;27:395407.
  • 17
    Hao Q, Saida T, Kuroki S, et al. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998;81:116126.
  • 18
    Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study. Neurology 1998;51:11101115.
  • 19
    Kusunoki S, Chiba A, Hitoshi S, et al. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 1995;18:409413.
  • 20
    Gregson NA, Rees JH, Hughes RA. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS). J Neuroimmunol 1997;73:2836.
  • 21
    Jacobs BC, van Doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol 1996;40:181187.
  • 22
    Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118 (Part 3):597605.
  • 23
    Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barre syndrome and Miller Fisher syndrome. J Infect Dis 1997;176 (Suppl 2):S150153.
  • 24
    Khalili-Shirazi A, Hughes RA, Brostoff SW, et al. T cell responses to myelin proteins in Guillain-Barre syndrome. J Neurol Sci 1992;111:200203.
  • 25
    Yuki N, Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 1998;154:1417.
  • 26
    Visser LH, van der Meche FG, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996;47:668673.
  • 27
    Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 1988;38:14391442.
  • 28
    Hemachudha T, Griffin DE, Chen WW, et al. Immunologic studies of rabies vaccination-induced Guillain-Barre syndrome. Neurology 1988;38:375378.
  • 29
    Langmuir AD, Bregman DJ, Kurland LT, et al. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984;119:841879.
  • 30
    Arnason BG, Asbury AK. Idiopathic polyneuritis after surgery. Arch Neurol 1968;18:500507.
  • 31
    Pascual JM, Redon J, Villoslada C, et al. Guillain-Barre syndrome after acute toxoplasma infection. Med Clin (Barc) 1984;83:351352.
  • 32
    Bossi P, Caumes E, Paris L, et al. Toxoplasma gondii-associated Guillain-Barre syndrome in an immunocompetent patient. J Clin Microbiol 1998;36:37243725.
  • 33
    Cuddon PA. Acute canine idiopathic polyradiculoneuropathy—electrophysiology, CSF analysis and immunology. In: Eighth Annual Symposium of the European Society of Veterinary Neurology, Limoges, France, 1994; 34–36.
  • 34
    Cuddon PA. Electrophysiological and immunological evaluation in coonhound paralysis. In: Eighth American College of Veterinary Internal Medicine Forum, Washington, DC, 1990; 1009–1012.
  • 35
    Lappin MR, Bush DJ, Reduker DW. Feline serum antibody responses to Toxoplasma gondii and characterization of target antigens. J Parasitol 1994;80:7380.
  • 36
    Dubey JP, Sundar N, Nolden CA, et al. Characterization of Toxoplasma gondii from raccoons (Procyon lotor), coyotes (Canis latrans), and striped skunks (Mephitis mephitis) in Wisconsin identified several atypical genotypes. J Parasitol 2007;93:15241527.
  • 37
    Hwang YT, Pitt JA, Quirk TW, et al. Seroprevalence of Toxoplasma gondii in mesocarnivores of the Canadian prairies. J Parasitol 2007;93:13701373.
  • 38
    Mitchell SM, Richardson DJ, Lindsay DS. Prevalence of agglutinating antibodies to Toxoplasma gondii in striped skunks (Mephitis mephitis), opossums (Didelphis virginiana), and raccoons (Procyon lotor) from Connecticut. J Parasitol 2006;92:664665.
  • 39
    Lindsay DS, Dubey JP, Butler JM, et al. Experimental tissue cyst induced Toxoplasma gondii infections in dogs. J Eukaryot Microbiol 1996;43:113S114S.
  • 40
    Dubey JP, Lappin MR, Thulliez P. Long-term antibody responses of cats fed Toxoplasma gondii tissue cysts. J Parasitol 1995;81:887893.
  • 41
    Liesenfeld O. Immune responses to Toxoplasma gondii in the gut. Immunobiology 1999;201:229239.
  • 42
    Dubey JP, Lappin MR. Toxoplasmosis and neosporosis. In: GreeneCE, ed. Infectious Diseases of the Dog and Cat, 3rd ed. St Louis, MO: Saunders Elsevier; 2006:754774.
  • 43
    Yu RK, Usuki S, Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain-Barre syndrome and related diseases. Infect Immun 2006;74:65176527.
  • 44
    Ahn HJ, Kim S, Nam HW. Host cell binding of GRA10, a novel, constitutively secreted dense granular protein from Toxoplasma gondii. Biochem Biophys Res Commun 2005;331:614620.
  • 45
    Attallah AM, Ismail H, Ibrahim AS, et al. Immunochemical identification and detection of a 36-kDa Toxoplasma gondii circulating antigen in sera of infected women for laboratory diagnosis of toxoplasmosis. J Immunoassay Immunochem 2006;27:4560.
  • 46
    Harkins D, Clements DN, Maley S, et al. Western blot analysis of the IgG responses of ruminants infected with Neospora caninum and with Toxoplasma gondii. J Comp Pathol 1998;119:4555.
  • 47
    Gehring R, Eggars B. Suspected post-vaccinal acute polyradiculoneuritis in a puppy. J S Afr Vet Assoc 2001;72:96.
  • 48
    Alford PL, Satterfield WC. Paralytic illness resembling inflammatory polyradiculoneuropathy in a chimpanzee. J Am Vet Med Assoc 1995;207:8385.
  • 49
    Tremblay ME, Closon A, D'Anjou G, et al. Guillain-Barre syndrome following H1N1 immunization in a pediatric patient. Ann Pharmacother 2010;44:13301333.